Syquant Capital’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History
Bought
Maintained
Sold
Syquant Capital's ONCE Position: Q4 2019 in Review
Syquant Capital sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2019, closing a stake of 20,587 shares — an estimated $2M sold.
Syquant Capital first reported a position in ONCE in Q1 2019 and held it in 3 quarters. The position peaked at $63.6M in Q1 2019. 0 funds tracked by Wall St. Rank hold ONCE as of Q4 2019.
- Syquant Capital reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
- Syquant Capital sold 20,587 Spark Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $2M.
- Syquant Capital first reported a position in Spark Therapeutics, Inc. Common Stock in Q1 2019 and held it in 3 quarters.
- Syquant Capital's Spark Therapeutics, Inc. Common Stock position peaked at $63.6M in Q1 2019.
- 0 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2019.
Based on Syquant Capital's 13F filing for Q4 2019, filed 8 Jan 2020.